BioSig Technologies, Inc. announced that it has entered into a securities purchase agreement with certain accredited investors to issue an aggregate of 1,129,996 common shares, par value $0.001 per share and warrants to purchase up to 564,998 shares of common stock at a purchase price of $0.52876 per share and a warrant to purchase one-half of a share for the gross proceeds of $597,496.68496 on October 12, 2023. The warrants have an exercise price of $0.46626 per share, will become exercisable six months after the date of issuance and will expire five and one-half years following the date of issuance. The securities were offered and sold in reliance on the exemption from registration under the Securities Act of 1933, as amended provided by Section 4(a)(2) and Regulation D under the Securities Act.